Zeno J. Frediani | People | Arnold & Porter

Zeno Frediani is a partner in the firm's competition group, representing clients in competition litigation and advising boards and senior management on their most consequential UK and EU competition law challenges. He has particular expertise in the pharmaceutical and life sciences sector. His practice spans competition damages litigation, merger control, cartel and behavioural investigations, restrictive agreements, and abuse of dominance.

Zeno has represented clients in competition damages proceedings in England & Wales and the Netherlands. His experience includes acting in claims arising from the EU trucks cartel, and defending a global pharmaceutical company in a follow-on action before the English High Court.

Zeno has led multi-jurisdictional merger control and foreign direct investment processes before the European Commission and the CMA, coordinating global filings on some of the most important transactions in recent years. He is known for bringing sound regulatory judgment to high-pressure situations, translating complex competition law issues into clear, actionable advice.

He leads Arnold & Porter's pro bono program in London, with a particular focus on advising charities and NGOs on regulatory, governance, and strategic legal issues. His pro bono experience also includes acting in an inquest and disability benefits appeals before the First-tier Tribunal.

Focus Areas

Experience

Palo Alto Networks in its US$25 billion acquisition of CyberArk.
Boston Scientific, as lead worldwide antitrust counsel, in securing antitrust clearance for the acquisition of Bolt Medical, Inc., a medical device company that is developing an intravascular lithotripsy (IVL) device to treat coronary and peripheral artery disease.
Touchlight Genetics in obtaining foreign investment clearances in relation to an agreement with Ceva Animal Health to use Touchlight’s dbDNA technology in animal health.
Novo Nordisk on European and other international antitrust and regulatory approvals in connection with its US$11 billion acquisition of three fill-finish sites from Novo Holdings A/S (Novo Holdings). As part of the deal, valued at US$16.5 billion, Novo Holdings acquires (through a merger) Catalent, Inc., a NYSE listed CDMO headquartered in New Jersey.
Boston Scientific in its $615 million acquisition of Apollo Endosurgery.

Pfizer in its $43 billion acquisition of Seagen Inc., a world-leader in antibody-drug conjugates (ADCs).
Lifeworks, in obtaining all competition and foreign direct investment clearances outside of Canada related to its C$2.9 billion sale to TELUS.
Bristol-Myers Squibb in its $4.1 billion acquisition of Turning Point Therapeutics.
Pfizer in obtaining merger control clearances in relation its $6.7 billion acquisition of Arena Pharmaceuticals.
Wheels Up Experience Inc. in obtaining foreign investment clearances in relation to its proposed acquisition of Air Partner plc.
Boston Scientific in relation to its $1.07 billion acquisition of Lumenis before multiple competition authorities worldwide.
Skyscanner in relation to its £1.4 billion acquisition by Ctrip.

Global pharmaceutical company in relation to an investigation by the Turkish Competition Authority.
Heineken, Diageo, AB InBev and Morrisons in relation to damages claims in the Netherlands and England & Wales arising out of the EU trucks cartel.
Global pharmaceutical company in relation to a follow-on competition damages action in the English High Court related to a decision by the European Commission.
Global pharmaceutical company in relation to investigations by the CMA and the European Commission into patent settlement agreements.
Global online retailer in relation to the CMA's investigation into anti-competitive agreements in the light fittings sector.

Pharmaceutical manufacturer in managing parallel trade and supply quotas.
Global pharmaceutical company on the competition law compliance of establishing agency arrangements for its EU-wide sales.
Five global travel companies in relation to the competition law compliance of industry collaboration and joint procurement.
Global pharmaceutical company in relation to the competition law compliance of distribution and pricing arrangements.
Government department in relation to the State aid compliance of a multi-million pound investment into a proposed telecommunications project.

Four children and their mother in securing the regularized immigration status of a family that fled Nigeria for the UK. This was a collaboration with Kids in Need of Defense UK (KIND), the preeminent non-governmental organization devoted to legal protection of unaccompanied children in immigration proceedings.
A father in the inquest into the deaths of his 23-month-old twins at the hands of their mother.
An individual in an appeal before the First Tier Tribunal challenging a decision of the Department for Work and Pensions not to award certain disability benefits.